KH001
/ HysensBio
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
March 18, 2025
KH-001-D201: A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity
(clinicaltrials.gov)
- P2 | N=171 | Completed | Sponsor: HysensBio Co., Ltd | Recruiting ➔ Completed
Trial completion • Immunology
October 29, 2024
Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity
(clinicaltrials.gov)
- P2 | N=120 | Recruiting | Sponsor: HysensBio Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology
August 30, 2024
A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries
(clinicaltrials.gov)
- P2 | N=12 | Not yet recruiting | Sponsor: Byoung-Moo Seo
New P2 trial
June 18, 2024
Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity
(clinicaltrials.gov)
- P2 | N=120 | Not yet recruiting | Sponsor: HysensBio Co., Ltd
New P2 trial • Immunology
May 23, 2024
KH-001-D201: A Study to Evaluate the Efficacy and Safety of KH001 in Patients With Dentin Hypersensitivity
(clinicaltrials.gov)
- P2 | N=171 | Recruiting | Sponsor: HysensBio Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology
February 19, 2024
KH-001-D201: A Study to Evaluate the Efficacy and Safety of KH001 in Patients With Dentin Hypersensitivity
(clinicaltrials.gov)
- P2 | N=171 | Not yet recruiting | Sponsor: HysensBio Co., Ltd
New P2 trial • Immunology
November 01, 2023
Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients
(clinicaltrials.gov)
- P1/2 | N=40 | Completed | Sponsor: HysensBio Co., Ltd | Recruiting ➔ Completed | Trial completion date: Dec 2023 ➔ Aug 2023 | Trial primary completion date: Nov 2023 ➔ Mar 2023
Trial completion • Trial completion date • Trial primary completion date • Immunology
September 22, 2023
Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients
(clinicaltrials.gov)
- P1/2 | N=40 | Recruiting | Sponsor: HysensBio Co., Ltd | Trial completion date: Mar 2023 ➔ Dec 2023 | Trial primary completion date: Jan 2023 ➔ Nov 2023
Trial completion date • Trial primary completion date • Immunology
1 to 8
Of
8
Go to page
1